Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons

Emerging Infectious Diseases

Volumn 15, Issue 9, 2009, Pages 1351-1358

  Piersimoni, Claudio ^a   Scarparo, Claudio ^b  

^a United Hospitals   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; MINOCYCLINE; RIFAMPICIN;

BACTERIUM ISOLATION; EXTRAPULMONARY INFECTION; HUMAN; IMMUNOCOMPETENCE; LABORATORY TEST; LUNG INFECTION; LYMPHADENITIS; MYCOBACTERIUM; NONHUMAN; OSTEOARTHROPATHY; PRACTICE GUIDELINE; PREVALENCE; REVIEW;

ADULT; ANIMALS; CHILD, PRESCHOOL; HUMANS; IMMUNOCOMPETENCE; INFANT; LYMPHADENITIS; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; PREVALENCE; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; TUBERCULOSIS, OSTEOARTICULAR;

EID: 70249107844     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1509.081259     Document Type: Review

References (40)

1. Falkinham JO. Epidemiology of infection by nontuberculosis mycobacteria. Clin Microbiol Rev. 1996;9:177-215.
2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease. Am J Respir Crit Care Med. 2007;175:367-416. DOI: 10.1164/rccm.200604-571ST (Pubitemid 46271561)
3. Marchevsky AM, Damsker B, Green S, Tepper S. The clinicopathological spectrum of nontuberculous mycobacterial osteoarticular infections. J Bone Joint Surg Am. 1985;67:925-929 (Pubitemid 15240318)
4. Dobos KM, Quinn FD, Ashford DA, Horsburgh CR, King CH. Emergence of a unique group of necrotizing mycobacterial diseases. Emerg Infect Dis. 1999;5:367-378
5. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42:1756-1763 DOI: 10.1086/504381 (Pubitemid 43839444)
6. Lai KK, Stottmeier KD, Sherman IH, McCabe WR. Mycobacterial cervical lymphadenopathy. Relation of etiologic agent to age. JAMA. 1984;251:1286-1288 DOI: 10.1001/jama.251.10.1286
7. Lindeboom JA, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R, Kuijper EJ. Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis. 2005;41:1569-1575 DOI: 10.1086/497834
8. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev. 2003;16:319-354 DOI: 10.1128/CMR.16.2.319-354.2003 (Pubitemid 36519815)
9. Ellison E, Lapuerta P, Martin SE. Fine needle aspiration diagnosis of mycobacterial lymphadenitis. Sensitivity and predictive value in the United States. Acta Cytol. 1999;43:153-157
10. Lindeboom JA, Kuijper EJ, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R. Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis. 2006;43:1547-1551 DOI: 10.1086/509326 (Pubitemid 44901895)
11. Lindeboom JA, Kuijper EJ, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM. Surgical excision versus antibiotic treatment for nontuberculous mycobacteria cervical lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis. 2007;44:1057-1064 DOI: 10.1086/512675 (Pubitemid 46580272)
12. Petitjean G, Fluckiger U, Schären S, Laifer G. Vertebral osteomyelitis caused by non-tuberculous mycobacteria. Clin Microbiol Infect. 2004;10:951-953 DOI: 10.1111/j.1469-0691.2004.00949.x (Pubitemid 39562460)
13. Elsayed S, Read R. Mycobacterium haemophilum osteomyelitis: case report and review of the literature. BMC Infect Dis. 2006;6:70. DOI: 10.1186/1471-2334-6-70
14. Zenone T, Boibieux A, Tigaud S, Fredenucci JF, Vincent V, Chidiac C, et al. Non-tuberculous mycobacterial tenosynovitis: a review. Scand J Infect Dis. 1999;31:221-228 DOI: 10.1080/00365549950163482
15. Theodorou DJ, Theodorou SJ, Kakitsubata Y, Sartoris DJ, Resnick D. Imaging characteristics and epidemiological features of atypical mycobacterial infections involving the musculoskeletal system. AJR Am J Roentgenol. 2001;176:341-349 (Pubitemid 32105639)
16. Casal M, Casal MM; Spanish Group of Mycobacteriology. Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int. J Tuberc Lung Dis. 2001;5:197-199
17. Hess CL, Wolock BS, Murphy MS. Mycobacterium marinum infections of the upper extremity. Plast Reconstr Surg. 2005;115:55e-9e. DOI: 10.1097/01.PRS. 0000153197.64808.B9
18. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med. 1994;154:1359-1364 DOI: 10.1001/archinte.154.12.1359
19. Aubry A, Chosidow O, Caumes E, Robert J, Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med. 2002;162:1746-1752 DOI: 10.1001/archinte.162.15.1746
20. Ang P, Rattana-Apiromyakij N, Goh CL. Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol. 2000;39:343-347 DOI: 10.1046/j.1365-4362.2000.00916.x
21. Bartralot R, Pujol RM, García-Patos V, Sitjas D, Martín-Casabona N, Coll P, et al. Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol. 2000;27:124-129 DOI: 10.1034/j.1600-0560.2000.027003124.x (Pubitemid 30113782)
22. Clinical and Laboratory Standards Institute. Laboratory detection and identification of mycobacteria: approved guideline. CLSI document M48-A. Wayne (PA): The Institute; 2008.
23. Cloud JL, Neal H, Rosenberry R, Turenne CY, Jama M, Hillyard DR, et al. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol. 2002;40:400-406 DOI: 10.1128/JCM.40.2.400-406.2002
24. Bråbäck M, Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother. 2002;46:1114-1116 DOI: 10.1128/AAC.46.4.1114-1116.2002
25. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes. Approved standard M24-A. Wayne (PA): The Committee; 2003.
26. World Health Organization. Buruli ulcer disease. Mycobacterium ulcerans infection: an overview of reported cases globally. Wkly Epidemiol Rec. 2004;79:194-200.
27. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis. 2002;8:167-170 (Pubitemid 34202439)
28. Marsollier L, Severin T, Aubry J, Merritt RW, Saint Andre JP, Legras P, et al. Aquatic snails, passive hosts of Mycobacterium ulcerans. Appl Environ Microbiol. 2004;70:6296-6298 DOI: 10.1128/AEM.70.10.6296-6298.2004
29. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Scott JT, et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health. 2004;9:1297-1304 DOI: 10.1111/j.1365-3156.2004. 01339.x
30. Guarner J, Bartlett J, Whitney EA, Raghunathan PL, Stienstra Y, Asamoa K, et al. Histopathologic features of Mycobacterium ulcerans infection. Emerg Infect Dis. 2003;9:651-656
31. Ellen DE, Stienstra Y, Teelken MA, Dijkstra PU, van der Graaf WT, van der Werf TS. Assessment of functional limitations caused by Mycobacterium ulcerans infections: towards a Buruli ulcer functional limitation score. Trop Med Int Health. 2003;8:90-96 DOI: 10.1046/j.1365-3156.2003.00976.x
32. Ross BC, Marino L, Oppedisano F, Edwards R, Robins-Browne RM, Johnson PD. Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol. 1997;35:1696-1700
33. Wansbrough-Jones M, Phillips R. Buruli ulcer: emerging from obscurity. Lancet. 2006;367:1849-1858 DOI: 10.1016/S0140-6736(06)68807-7
34. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, et al. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother. 2005;49:3182-3186 DOI: 10.1128/AAC.49.8.3182-3186.2005
35. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15:716-746 DOI: 10.1128/CMR.15.4.716-746.2002
36. Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 2005;13:7-10. DOI: 10.1016/j.tim.2004.11.004 (Pubitemid 40082390)
37. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo- outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453-490 DOI: 10.1146/annurev.micro.52.1.453
38. Uslan DZ, Kowalski TJ, Wengenack LW, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria. Arch Dermatol. 2006;142:1287-1292 DOI: 10.1001/archderm.142.10.1287
39. Winthrop KL, Abrams M, Yakrus M, Schwartz I, Ely J, Gillies D, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med. 2002;346:1366-1371 DOI: 10.1056/NEJMoa012643 (Pubitemid 34754609)
40. Turenne CY, Tschetter L, Wolfe J, Kabani A. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol. 2001;39:3637-3648 DOI: 10.1128/JCM.39.10.3638-3648.2001 (Pubitemid 32954514)